During a meeting of the AML Hub Steering Committee on June 1, 2022, Gail Roboz, Weill Cornell Medicine, New York, US, chaired a discussion session on the topic of “How to provide better supportive care”, which was identified as an unmet educational need within AML treatment.
Roboz starts by introducing “supportive care” as a subject that is often overlooked when presenting information to clinicians and patients, and then invites the committee to comment on the prophylaxis of infectious diseases in their own clinical practice. The committee then offers recommendations for coping with diagnosis and intensive chemotherapy, exploring subjects such as the evolving literature on this topic, and the patient’s need for continuity. Finally, they cover the diet in patients with AML, and Uwe Platzbecker concludes by highlighting the impact that excessive use of prophylactic supplementation can have on the microbiome and recommending careful selection within treatment plans.
How to provide better supportive care
What has ASH 2020 taught us about advancing frontline chemotherapy in AML?
Increased understanding of the driving genetic and epigenetic factors of acute myeloid leukemia (AML) in recent years has helped to refine novel chemotherapy combinations in...
ASH 2020 | Practice-changing abstracts in acute myeloid leukemia
Did you miss ASH 2020? The AML Hub was pleased to virtually attend the 62nd ASH Annual Meeting & Exposition, December 5-8 2020, and has developed a downloadable resource on the...
Subscribe to get the best content related to AML delivered to your inbox